Anti-inflammatory effect of 1α,25-dihydroxyvitamin D3 in human coronary arterial endothelial cells: Implication for the treatment of Kawasaki disease

Journal of Steroid Biochemistry and Molecular Biology

Volumn 113, Issue 1-2, 2009, Pages 134-138

  Suzuki, Yasuo ^a   Ichiyama, Takashi ^a   Ohsaki, Ayami ^a   Hasegawa, Shunji ^a   Shiraishi, Masahiro ^a   Furukawa, Susumu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

1 ,25 Dihydroxyvitamin D3; Coronary arterial endothelial cells; E selectin; NF B; Vitamin D receptor

Indexed keywords

CALCITRIOL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; CORONARY VESSELS; COS CELLS; E-SELECTIN; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; JURKAT CELLS; MUCOCUTANEOUS LYMPH NODE SYNDROME; NF-KAPPA B; RECEPTORS, CALCITRIOL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D;

EID: 59849122111     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.12.004     Document Type: Article

References (39)

1. Kawasaki T., Kosaki F., Ogawa S., Shigemitsu I., and Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54 (1974) 271-276
2. Fujiwara H., and Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics 61 (1978) 100-107
3. Kato H., Sugimura T., Akagi T., Sato N., Hashino K., Maeno Y., Kazue T., Eto G., and Yamakawa R. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94 (1996) 1379-1385
4. Furukawa S., Matsubara T., Jujoh K., Yone K., Sugawara T., Sasai K., Kato H., and Yabuta K. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin. Immunol. Immunopathol. 48 (1988) 247-251
5. Furukawa S., Matsubara T., Yone K., Hirano Y., Okumura K., and Yabuta K. Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-α and interleukin 6 in serum. Eur. J. Pediatr. 151 (1992) 44-47
6. Furukawa S., Matsubara T., Umezawa Y., Okumura K., and Yabuta K. Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease. J. Pediatr. 124 (1994) 721-725
7. Ichiyama T., Yoshitomi T., Nishikawa M., Fujiwara M., Matsubara T., Hayashi T., and Furukawa S. NF-κB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease. Clin. Immunol. 99 (2001) 373-377
8. Matsubara T., Ichiyama T., and Furukawa S. Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin. Exp. Immunol. 141 (2005) 381-387
9. Furukawa S., Imai K., Matsubara T., Yone K., Yachi A., Okumura K., and Yabuta K. Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. Arthritis Rheum. 35 (1992) 672-677
10. Kim D.S., and Lee K.Y. Serum soluble E-selectin levels in Kawasaki disease. Scand. J. Rheumatol. 23 (1994) 283-286
11. Yee Y.K., Chintalacharuvu S.R., Lu J., and Nagpal S. Vitamin D receptor modulators for inflammation and cancer. Mini Rev. Med. Chem. 5 (2005) 761-778
12. Equils O., Naiki Y., Shapiro A.M., Michelsen K., Lu D., Adams J., and Jordan S. 1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin. Exp. Immunol. 143 (2006) 58-64
13. 3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164 (2000) 2405-2411
14. 3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J. Immunol. 167 (2001) 4974-4980
15. 4+ T cells. J. Immunol. 168 (2002) 1181-1189
16. 3 in macrophages. J. Steroid Biochem. Mol. Biol. 103 (2007) 558-562
17. 3 inhibits tumor necrosis factor-α-induced adhesion molecule expression in endothelial cells. Cell Biol. Int. 30 (2006) 365-375
18. Burns J.C., Capparelli E.V., Brown J.A., Newburger J.W., and Glode M.P. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr. Infect. Dis. J. 17 (1998) 1144-1148
19. Wallace C.A., French J.W., Kahn S.J., and Sherry D.D. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 105 (2000) E78
20. Boehme M.W., Schmitt W.H., Youinou P., Stremmel W.R., and Gross W.L. Clinical relevance of elevated serum thrombomodulin and soluble E-selectin in patients with Wegener's granulomatosis and other systemic vasculitides. Am. J. Med. 101 (1996) 387-394
21. Zakeri S.M., Meyer H., Meinhardt G., Reinisch W., Schrattbauer K., Knoefler M., and Block L.H. Effects of trovafloxacin on the IL-1-dependent activation of E-selectin in human endothelial cells in vitro. Immunopharmacology 48 (2000) 27-34
22. 3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell Biol. 15 (1995) 5789-5799
23. 3 receptor RNA: expression in hematopoietic cells. Blood 77 (1991) 1238-1247
24. Zhang Z., Schwartz S., Wager L., and Miller W. A greedy algorithm for aligning DNA sequences. J. Comput. Biol. 7 (2000) 203-214
25. Papapoulos S.E., Clemens T.L., Sandler L.M., Fraher L.J., Winer J., and O'Riordan J.L. The effect of renal function on changes in circulating concentrations of 1,25-dihydroxycholecalciferol after an oral dose. Clin. Sci. 62 (1982) 427-429
26. Levine B.S., Singer F.R., Bryce G.F., Mallon J.P., Miller O.N., and Coburn J.W. Pharmacokinetics and biologic effects of calcitriol in normal humans. J. Lab. Clin. Med. 105 (1985) 239-246
27. Do J.E., Kwon S.Y., Park S., and Lee E.S. Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behçet's disease. Rheumatology 47 (2008) 840-848
28. Stio M., Martinesi M., Bruni S., Treves C., Mathieu C., Verstuyf A., D'Albasio G., Bagnoli S., and Bonanomi A.G. The Vitamin D analogue TX 527 blocks NF-κB activation in peripheral blood mononuclear cells of patients with Crohn's disease. J. Steroid Biochem. Mol. Biol. 103 (2007) 51-60
29. Martinesi M., Treves C., D'Albasio G., Bagnoli S., Bonanomi A.G., and Stio M. Vitamin D derivatives induce apoptosis and downregulate ICAM-1 levels in peripheral blood mononuclear cells of inflammatory bowel disease patients. Inflamm. Bowel Dis. 14 (2008) 597-604
30. Smolders J., Damoiseaux J., Menheere P., and Hupperts R. Vitamin D as an immune modulator in multiple sclerosis, a review. J. Neuroimmunol. 194 (2008) 7-17
31. 3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J. Neurosci. Res. 85 (2007) 2480-2490
32. 3 in experimental sepsis. Int. J. Med. Sci. 4 (2007) 190-195
33. Patel S., Farragher T., Berry J., Bunn D., Silman A., and Symmons D. Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum. 56 (2007) 2143-2149
34. Furusho K., Kamiya T., Nakano H., Kiyosawa N., Shinomiya K., Hayashidera T., Tamura T., Hirose O., Manabe Y., Yokoyama T., Kawarano M., Baba K., Baba K., and Mori C. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2 (1984) 1055-1058
35. Newburger J.W., Takahashi M., Burns J.C., Beiser A.S., Chung K.J., Duffy C.E., Glode M.P., Mason W.H., Reddy V., Sanders S.P., Shulman S.T., Wiggins J.W., Hicks R.V., Fulton D.R., Lewis A.B., Leung D.Y.M., Colton T., Rosen F.S., and Melish M.E. The treatment of Kawasaki syndrome with intravenous gamma globulin. N. Engl. J. Med. 315 (1986) 341-347
36. Newburger J.W., Takahashi M., Beiser A.S., Burns J.C., Bastian J., Chung K.J., Colan S.D., Duffy C.E., Fulton D.R., Glode M.P., Mason W.H., Meissner H.C., Rowley A.H., Shulman S.T., Reddy V., Sundel R.P., Wiggins J.W., Colton T., Melish M.E., and Rosen F.S. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N. Engl. J. Med. 324 (1991) 1633-1639
37. Dale R.C., Saleem M.A., Daw S., Dillon M.J., Saleem M.A., Daw S., and Dillon M.J. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. J. Pediatr. 137 (2000) 723-726
38. Okada Y., Shinohara M., Kobayashi T., Inoue Y., Tomomasa T., Kobayashi T., and Morikawa A. Gunma Kawasaki Disease Study Group, Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children. J. Pediatr. 143 (2003) 363-367
39. Sundel R.P., Baker A.L., Fulton D.R., and Newburger J.W. Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial. J. Pediatr. 142 (2003) 611-616